Dominguez, Celia,Munoz-Sanjuan, Ignacio,Luckhurst, Christopher A.,Allen, Daniel R.,Raphy, Gilles,Burli, Roland W.,Breccia, Perla,Haughan, Alan F.,Wishart, Grant,Hughes, Samantah J.,Jarvis, Rebecca E.
申请号：
AU2015270926
公开号：
AU2015270926A1
申请日:
2015.06.01
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of their use. The condition or disorder mediated by HDAC comprises a neurodegenerative pathology. Accordingly, also provided is a method of treating a neurodegenerative pathology mediated by HDAC in a subject in need of such a treatment, comprising administering to the subject a therapeutically effective amount of at least one compound, or pharmaceutically acceptable salt thereof, described herein.
